Biblio

6 Ergebnisse exportiert:
Autor Titel Typ [ Jahr(Desc)]
Filterkriterien: Autor is Tammela, Tuomas  [Alle Filter deaktivieren]
2003
Jeltsch M, Tammela T, Alitalo K, Wilting J. Genesis and pathogenesis of lymphatic vessels. Cell Tissue Res [Internet]. 2003;314(1):69 - 84. http://view.ncbi.nlm.nih.gov/pubmed/12942362PDF Icon Michael Jeltsch et al., Cell and Tissue Research 2003 (562.33 KB)
2005
Baluk P, Tammela T, Ator E, Lyubynska N, Achen MG, Hicklin DJ, u. a.. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest [Internet]. 2005;115(2):247 - 57. http://view.ncbi.nlm.nih.gov/pubmed/15668734PDF Icon Peter Baluk et al., Journal of Clinical Investigation 2005 (1.89 MB)
2007
Tammela T, He Y, Lyytikkä J, Jeltsch M, Markkanen J, Pajusola K, u. a.. Distinct architecture of lymphatic vessels induced by chimeric vascular endothelial growth factor-C/vascular endothelial growth factor heparin-binding domain fusion proteins. Circ Res [Internet]. 2007;100(10):1468 - 75. http://view.ncbi.nlm.nih.gov/pubmed/17478733PDF Icon Tuomas Tammela et al., Circulation Research 2007 (1.1 MB)
Keskitalo S, Tammela T, Lyytikka J, Karpanen T, Jeltsch M, Markkanen J, u. a.. Enhanced capillary formation stimulated by a chimeric vascular endothelial growth factor/vascular endothelial growth factor-C silk domain fusion protein. Circ Res [Internet]. 2007;100(10):1460 - 7. http://view.ncbi.nlm.nih.gov/pubmed/17478734PDF Icon Salla Keskitalo et al., Circulation Research 2007 (1.98 MB)
2010
Tvorogov D, Anisimov A, Zheng W, Leppänen V-M, Tammela T, Laurinavicius S, u. a.. Effective suppression of vascular network formation by combination of antibodies blocking VEGFR ligand binding and receptor dimerization. Cancer Cell [Internet]. 2010;18(6):630 - 40. http://view.ncbi.nlm.nih.gov/pubmed/21130043PDF Icon Denis Tvorogov et al., Cancer Cell 2010 (1.3 MB)PDF Icon Denis Tvorogov et al., Cancer Cell 2010, supplement (828.69 KB)
Bry M, Kivelä R, Holopainen T, Anisimov A, Tammela T, Soronen J, u. a.. Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation. Circulation [Internet]. 2010;122(17):1725 - 33. http://view.ncbi.nlm.nih.gov/pubmed/20937974PDF Icon Maija Bry et al., Circulation 2010 (2.23 MB)PDF Icon Maija Bry et al., Circulation 2010, supplement (17.77 MB)